Freestone Capital Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,016
| Closed | -$286K | – | 440 |
|
|
2022
Q2 | $286K | Sell |
1,016
-397
| -28% | -$112K | 0.01% | 342 |
|
|
2022
Q1 | $369K | Sell |
1,413
-43
| -3% | -$11.2K | 0.01% | 426 |
|
|
2021
Q4 | $320K | Buy |
+1,456
| New | +$320K | 0.01% | 390 |
|
|
2021
Q3 | – | Sell |
-1,244
| Closed | -$251K | – | 442 |
|
|
2021
Q2 | $251K | Sell |
1,244
-38
| -3% | -$7.67K | 0.01% | 367 |
|
|
2021
Q1 | $275K | Buy |
1,282
+326
| +34% | +$69.9K | 0.02% | 341 |
|
|
2020
Q4 | $226K | Buy |
956
+234
| +32% | +$55.3K | 0.01% | 333 |
|
|
2020
Q3 | $196K | Buy |
+722
| New | +$196K | 0.01% | 321 |
|